Skip to main content
. 2024 Jul 23;15:1407396. doi: 10.3389/fendo.2024.1407396

Table 1.

Asymptomatic and symptomatic recruited inpatients and hemato-biochemical analysis (Student’s t-test).

Parameters Asymptomatic
Mean ± SD
Symptomatic
Mean ± SD
p
Age 42 72 ± 5 77 ± 7
RBC (×106/μL) 42 4.4 ± 0.5 4.2 ± 0.6 n.s.
WBC (×103/μL) 42 8 ± 2 7 ± 2 n.s.
HGB (g/dL) 42 13.4 ± 1.2 12.8 ± 1.9 n.s.
MCV (fL) 42 89 ± 6 90 ± 5 n.s.
MCH (pg) 42 31 ± 2 30 ± 2 n.s.
MCHC (g/dL) 42 34 ± 1 34 ± 1 n.s.
RDW-CV (%) 41 13.2 ± 0.9 13.5 ± 0.9 n.s.
RDW-SD (fL) 41 42.8 ± 3.9 43.9 ± 4.2 n.s.
Neutrophils (%) 41 65 ± 7 64 ± 8 n.s.
Lymphocytes (%) 41 26 ± 6 26 ± 8 n.s.
Monocytes (%) 41 6.5 ± 1.5 7.6 ± 1.6 0.036
Eosinophils (%) 41 2.2 ± 1.3 2.0 ± 1.7 n.s.
Basophils (%) 41 0.4 ± 0.2 0.5 ± 0.3 n.s.
Platelets (×103/μL) 42 229 ± 50 229 ± 69 n.s.
Neutrophils/Lymphocytes 41 2.7 ± 0.8 2.8 ± 1.2 n.s.
MPV (fL) 42 11 ± 1 11 ± 1 n.s.
Urea (mg/dL) 42 39 ± 12 36 ± 11 n.s.
Creatinine (mg/dL) 42 1.06 ± 0.31 1.04 ± 0.27 n.s.
eGFR (mL/min) 42 80 ± 26 79 ± 20 n.s.
Uric acid (mg/dL) 42 5.42 ± 1.13 5.31 ± 1.65 n.s.
Sodium (mmol/L) 42 140 ± 2 141 ± 3 n.s.
Calcium tot (mg/dL) 42 9.37 ± 0.49 9.53 ± 0.52 n.s.
Total proteins (g/dL) 42 6.67 ± 0.41 6.62 ± 0.46 n.s.
Albumin (g/dL) 31 4.1 ± 0.2 3.8 ± 0.4 0.005
Total bilirubin (mg/dL) 42 0.65 ± 0.31 0.76 ± 0.36 n.s.
Direct bilirubin (mg/dL) 42 0.22 ± 0.09 0.27 ± 0.12 n.s.
Indirect bilirubin (mg/dL) 42 0.43 ± 0.22 0.49 ± 0.25 n.s.
AST (GOT) (U/L) 42 24 ± 16 24 ± 8 n.s.
ALT (GPT) (U/L) 42 22 ± 18 23 ± 15 n.s.
GGT (U/L) 42 26 ± 14 54 ± 77 n.s.
Total amylase (U/L) 42 76 ± 29 84 ± 27 n.s.
Creatine Kinase (U/L) 42 139 ± 144 100 ± 87 n.s.
Glucose (mg/mL) 42 112 ± 34 96 ± 10 n.s.
Total cholesterol (mg/dL) 42 150 ± 26 149 ± 46 n.s.
LDL (mg/dL) 42 81 ± 23 83 ± 36 n.s.
HDL (mg/dL) 42 48 ± 9 47 ± 17 n.s.
Triglycerides (mg/dL) 42 131 ± 40 119 ± 47 n.s.
Lactate dehydrogenase (U/L) 42 189 ± 52 179 ± 46 n.s.
C-reactive protein (mg/dL) 37 0.46 ± 0.76 1.08 ± 1.96 n.s.

In bold the significant p values. (< 0.05). ns, not significant.